Omeros OMER
NASDAQ OMER
$18.61 +0.14 (+0.76%)
At close: Oct 2, 2026 · 4:00 PM EDT

Omeros (OMER) Selling, General & Administrative (2010 - 2026)

Updated

Omeros' Selling, General & Administrative was $13.86 million in Q2 2026, up 34.0% from $10.35 million a year earlier and up 3.7% from the prior quarter.

Analysis

Omeros (OMER) Selling, General & Administrative (2010 - 2026) Analysis & Trends

On a trailing twelve-month basis, Omeros' Selling, General & Administrative was $47.26 million through Jun 30, 2026, up 10.4% year-over-year; for FY2025, it was $41.5 million, down 12.5% from FY2024.

  • Selling, General & Administrative has now declined for four consecutive years, with a five-year compound annual growth rate of -3.4% (FY2020 to FY2025).
  • In earlier years, Selling, General & Administrative was $47.43 million in FY2024 (-4.5%), $49.66 million in FY2023 (-2.0%), $50.67 million in FY2022 (-7.6%) and $54.84 million in FY2021 (+11.2%).
  • The Q2 2026 figure marks the highest quarterly Selling, General & Administrative since Q3 2023.
  • Compared with a year earlier, Selling, General & Administrative was higher in two of the last eight quarters, with an average decline of 3.9%.
  • The best year-over-year quarter for Selling, General & Administrative over five years was Q3 2023 (growth of 34.6%); the worst was Q3 2024 (a decline of 31.0%).
  • Per Business Quant data, OMER's Selling, General & Administrative in the three quarters before Q2 2026 was $13.37 million (Q1 2026), $9.64 million (Q4 2025) and $10.4 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 3.43 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 6.43 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 3.63 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 2.90 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -3.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -5.65 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 1.75 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 1.92 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 3.41 Bn
10 Omeros 1.34 Bn 1.34 Bn 27.73 Mn 13.86 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 13.86 Mn
Mar 31, 2026 13.37 Mn
Dec 31, 2025 9.64 Mn
Sep 30, 2025 10.40 Mn
Jun 30, 2025 10.35 Mn
Mar 31, 2025 11.12 Mn
Dec 31, 2024 10.04 Mn
Sep 30, 2024 11.32 Mn
Jun 30, 2024 13.81 Mn
Mar 31, 2024 12.26 Mn
Dec 31, 2023 10.88 Mn
Sep 30, 2023 16.42 Mn
Jun 30, 2023 11.26 Mn
Mar 31, 2023 11.10 Mn
Dec 31, 2022 13.59 Mn
Sep 30, 2022 12.20 Mn
Jun 30, 2022 13.92 Mn
Mar 31, 2022 10.96 Mn
Dec 31, 2021 12.56 Mn
Sep 30, 2021 14.01 Mn
API Access

Omeros Selling, General & Administrative API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=OMER&period=max&api_key=YOUR_API_KEY